Effects of Capsaicin on Rat Liver S9-Mediated Metabolism and DNA Binding of Aflatoxin

Nutrition and Cancer

Volumn 15, Issue 1, 1991, Pages 27-32

  Teel, R W ^a  

^a Linda University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AFLATOXIN; CAPSAICIN;

ANIMAL TISSUE; ARTICLE; DNA BINDING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIVER; MALE; NONHUMAN; RAT;

AFLATOXIN B1; AFLATOXINS; ANIMAL; BIOTRANSFORMATION; CAPSAICIN; CARCINOGENS; CYTOCHROME P-450 ENZYME SYSTEM; DNA-BINDING PROTEINS; LIVER; MALE; RATS; RATS, INBRED STRAINS; THYMUS EXTRACTS;

ANIMALIA; CAPSICUM; CAPSICUM FRUTESCENS;

EID: 0026011556     PISSN: 01635581     EISSN: 15327914     Source Type: Journal    
DOI: 10.1080/01635589109514108     Document Type: Article

References (26)

1. Lee, S.O.: “Studies on the Influence of Diets and Lipotrophic Substances Upon the Various Organs and Metabolic Changes in Rabbits on Long-Term Feeding of Red Pepper.” Korean J Intern Med 6, 471–481, 1963.
2. Buck, S.H., and Burks, T.F.: “Capsaicin: Hot New Pharmacological Tool.” Trends Pharmacol Sci 4, 84-87,1983.
3. Issekutz, B., Lichtneckert, I., and Winter, M.: “Effect of Histamine, Capsaicine and Brocaine on Heat Regulation.” Arch Int Pharmacodyn 81, 35–46, 1950.
4. Toda, N., and Usui, H.: “Cardiovascular Effects of Capsaicin in Dogs and Rabbits.” J Pharmacol Exp Ther 181, 512–521, 1972.
5. Jhamandas, K., Yaksh, T.L., Harty, G., Szolcsanyi, J., and Go, V.L.W.: “Action of Intrathecal Capsaicin and its Structural Analogues on the Content and Release of Spinal Substance P: Selectivity of Action and Relationship to Analgesia.” Brain Res 306, 215–225, 1984.
6. Viranuvatti, V., Kalayasiri, C., Chearani, O., and Plengvanit, U.: “Effect of Capsaicin Solution on Human Gastric Mucosa as Observed Gastroscopically.” Am J Gastroenterol 58, 225–232, 1972.
7. Miller, M.S., Brendel, K., Burks, T., and Sipes, G.: “Interaction of Capsaicinoids With Drug-Metabolizing Systems. Relationship to Toxicity.” Biochem Pharmacol 32, 547–551, 1983.
8. Modly, C.E., Das, M., Don, P.S.C., Marcelo, C.L., Mukhtar, H., and Bickers, D.R.: “Capsaicin as an In Vitro Inhibitor of Benzo[alpyrene Metabolism and its DNA Binding in Human and Murine Keratinocytes.” Drug Metab Dispos 14, 413–416, 1986.
9. Busby, W.F., and Wogan, G.N.: “Aflatoxins.” In Chemical Carcinogens, CE Searle (ed). Washington, DC: American Chemical Society, 1984, pp 945–1136.
10. Stoloff, L.: “Occurrence of Mycotoxins in Food and Feeds.” In Mycotoxins and Other Fungal Related Food Problems, JV Rodricks (ed). Washington, DC: American Chemical Society, 1975, pp 23–50.
11. Guengerich, F.P.: “Roles of Cytochrome P-450 Enzymes in Chemical Carcinogenesis and Cancer Chemotherapy.” Cancer Res 48, 2946–2954, 1988.
12. Maron, D.M., and Ames, B.: “Revised Methods for the Salmonella Mutagenicity Test.” Mutat Res 113, 173-215, 1983.
13. Lowry, D.H., Rosebrough, N.J., Farr, A.L., and Randall, R.J.: “Protein Measurement With the Folin Phenol Reagent.” J Biol Chem 193, 265–275, 1951.
14. Lotlikar, P.D., Raj, H.G., Bohm, L.S., Ho, L.L., Jhee, E.C., et al.: “A Mechanism of Inhibition of Aflatoxin BrDNA Binding in the Liver by Phenobarbital Treatment of Rats.” Cancer Res 49, 951–957, 1989.
15. Kensler, T.W., Egner, P.A., Davidson, N.E., Roebuck, B.D., Pikul, A., et al.: “Modulation of Aflatoxin Metabolism, Aflatoxin-N7-guanine Formation and Hepatic Tumorigenesis in Rats Fed Ethoxyquin: Rate of Induction of Glutathione S-Transferases.” Cancer Res 46, 3924–3931, 1986.
16. Maniatus, T., Fritsch, E.F., and Sambrooks, J.: Molecular Cloning: A Laboratory Manual. Cold Springs Harbor, NY: Cold Springs Harbor Laboratory, 1982, p 458.
17. Burton, K.A.: “Study of the Conditions and Mechanisms of the Diphenylamine Reaction for the Colorimetric Estimation of Deoxyribonucleic Acid.” Biochemistry 162, 315–323, 1950.
18. Mandal, S., Ahuja, A., Shivapurkur, N.M., Cheng, S., Groopman, J.D., et al.: “Inhibition of Aflatoxin B, Mutagenesis in Salmonella typhimurium and DNA Damage in Cultured Rat and Human Tracheobronchial Tissues by Ellagic Acid.” Carcinogenesis 8, 1651–1656, 1987.
19. Campbell, T.G., and Hayes, J.R.: “The Role of Aflatoxin Metabolism in its Toxic Lesion.” Toxicol Appl Pharmacol 35, 199–222, 1976.
20. Coulombe, R.A., Shelton, D.W., Sinnhuber, R.O., and Nixon, J.E.: “Comparative Mutagenicity of Aflatoxins Using a Salmonella/Trout Hepatic Enzyme Activation System.” Carcinogenesis 3, 1261–1264, 1982.
21. Ramsdell, H.S., and Eaton, D.L.: “Species Susceptibility to Aflatoxin Bt Carcinogenesis: Comparative Kinetics of Microsomal Biotransformation.” Cancer Res 50, 615–620, 1990.
22. Swenson, D.H., Lin, J.K., Miller, E.C., and Miller, J.A.: “Aflatoxin Br 2, 3-Oxide as a Probable Intermediate in the Covalent Binding of Aflatoxin Bj and B2 to Rat Liver DNA and Ribosomal RNA In Vivo Cancer Res 37, 172–181, 1977.
23. Essigmann, J.M., Croy, R.G., Bennett, R.A., and Wogan, G.N.: “Metabolic Activation of Aflatoxin Bj: Patterns of DNA Adduct Formation, Removal and Excretion in Relation to Carcinogenesis.” Drug Metab Rev 13, 581-602, 1982.
24. Degen, G.H., and Neumann, H.G.: “Differences in Aflatoxin B,-Susceptibility of Rat and Mouse are Correlated With the Capability In Vivo to Inactivate Aflatoxin Br Epoxide.” Carcinogenesis 2, 299–306, 1981.
25. Monroe, D.H., and Eaton, D.L.: “Comparative Effects of Butylated Hydroxyanisole on Hepatic In Vivo DNA Binding and In Vitro Biotransformation of Aflatoxin Bj in the Rat and Mouse.” Toxicol Appl Pharmacol 90, 401–409, 1987.
26. Miller, M.S., Brendel, K., Burks, T.F., and Sipes, I.G.: “Interaction of Capsaicinoids With Drug-Metabolizing Systems.” Biochem Pharmacol 32, 547–551, 1983.